21.62 USD
+0.11
0.51%
At close Feb 14, 4:00 PM EST
After hours
21.62
+0.00
0.00%
1 day
0.51%
5 days
0.32%
1 month
14.69%
3 months
7.67%
6 months
24.90%
Year to date
13.13%
1 year
-2.35%
5 years
-26.21%
10 years
-22.65%
 

About: Envista Holdings Corp is a dental products company. It develops, manufactures, and markets portfolios of dental consumables, equipment, and services to dental professionals. The company's business consists of two segments comprising Specialty Products and Technologies and Equipment and Consumables. The Company's Specialty Products & Technologies segment develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics, and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. The Company's Equipment & Consumables segment manufactures dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems.

Employees: 12,300

0
Funds holding %
of 6,831 funds
0
Analysts bullish %
of 5 analysts

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

753% more call options, than puts

Call options by funds: $13.9M | Put options by funds: $1.63M

200% more funds holding in top 10

Funds holding in top 10: 1 [Q2] → 3 (+2) [Q3]

12% more capital invested

Capital invested by funds: $3.45B [Q2] → $3.85B (+$401M) [Q3]

6% more first-time investments, than exits

New positions opened: 51 | Existing positions closed: 48

0% more funds holding

Funds holding: 290 [Q2] → 291 (+1) [Q3]

6% less repeat investments, than reductions

Existing positions increased: 100 | Existing positions reduced: 106

7.12% less ownership

Funds ownership: 120.6% [Q2] → 113.48% (-7.12%) [Q3]

Research analyst outlook

5 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$18
17%
downside
Avg. target
$20
7%
downside
High target
$22
2%
upside

5 analyst ratings

positive
0%
neutral
80%
negative
20%
Wells Fargo
Vik Chopra
90% 1-year accuracy
9 / 10 met price target
3%downside
$21
Equal-Weight
Maintained
6 Feb 2025
Morgan Stanley
Erin Wright
59% 1-year accuracy
17 / 29 met price target
7%downside
$20
Equal-Weight
Maintained
6 Feb 2025
Piper Sandler
Jason Bednar
44% 1-year accuracy
17 / 39 met price target
17%downside
$18
Neutral
Maintained
3 Feb 2025
Jefferies
Glen Santangelo
50% 1-year accuracy
5 / 10 met price target
2%upside
$22
Hold
Maintained
23 Jan 2025
Mizuho
Steven Valiquette
60% 1-year accuracy
3 / 5 met price target
7%downside
$20
Underperform
Initiated
4 Dec 2024

Financial journalist opinion

Based on 9 articles about NVST published over the past 30 days

Neutral
Zacks Investment Research
6 days ago
NVST Stock Up on Q4 Earnings and Revenue Beat, Operating Margin Crashes
Envista delivers better-than-expected top and bottom-line results for the fourth quarter of 2024.
NVST Stock Up on Q4 Earnings and Revenue Beat, Operating Margin Crashes
Neutral
Seeking Alpha
1 week ago
Envista Holdings Corporation (NVST) Q4 2024 Earnings Call Transcript
Envista Holdings Corporation (NYSE:NVST ) Q4 2024 Earnings Conference Call February 5, 2025 5:30 PM ET Company Participants Jim Gustafson – Vice President-Investor Relations Paul Keel – President and Chief Executive Officer Eric Hammes – Chief Financial Officer Conference Call Participants Elizabeth Anderson – Evercore ISI Jon Block – Stifel Ahmed Muhammad – Leerink Partners Jeff Johnson – Baird Kevin Caliendo – UBS Erin Wright – Morgan Stanley Steven Valiquette – Mizuho Securities Brandon Vazquez – William Blair Vik Chopra – Wells Fargo Operator Hello. My name is David, and I'll be your conference call facilitator this afternoon.
Envista Holdings Corporation (NVST) Q4 2024 Earnings Call Transcript
Neutral
Zacks Investment Research
1 week ago
Here's What Key Metrics Tell Us About Envista (NVST) Q4 Earnings
While the top- and bottom-line numbers for Envista (NVST) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Here's What Key Metrics Tell Us About Envista (NVST) Q4 Earnings
Positive
Zacks Investment Research
1 week ago
Envista (NVST) Beats Q4 Earnings and Revenue Estimates
Envista (NVST) came out with quarterly earnings of $0.24 per share, beating the Zacks Consensus Estimate of $0.23 per share. This compares to earnings of $0.29 per share a year ago.
Envista (NVST) Beats Q4 Earnings and Revenue Estimates
Neutral
PRNewsWire
1 week ago
Envista Reports Fourth Quarter 2024 Results
BREA, Calif. , Feb. 5, 2025 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) today announced results for the quarter ended December 31, 2024.
Envista Reports Fourth Quarter 2024 Results
Neutral
PRNewsWire
1 week ago
Envista to hold Capital Markets Day on March 5, 2025
BREA, Calif. , Feb. 4, 2025 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the company will hold a Capital Markets Day on Wednesday, March 5, from 9:00 a.m.
Envista to hold Capital Markets Day on March 5, 2025
Positive
Zacks Investment Research
2 weeks ago
Envista (NVST) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
Envista (NVST) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Envista (NVST) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
Neutral
PRNewsWire
2 weeks ago
Update: Envista Schedules Fourth Quarter 2024 Earnings Call
BREA, Calif. , Jan. 27, 2025 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") will report financial results for its fourth quarter 2024 on Wednesday, February 5, 2025.
Update: Envista Schedules Fourth Quarter 2024 Earnings Call
Positive
Seeking Alpha
3 weeks ago
Envista Is A Margin Improvement Story (Rating Upgrade)
I upgrade Envista stock to a buy due to its potential for increased profitability in 2025. The Implants segment, NVST's largest business unit, is expected to witness positive sales expansion in the coming quarters by capitalizing on its brand strength in a market with favorable recovery prospects. The clear aligner business targets to achieve positive operating profit for the current year, considering the appointment of new leadership and the company management's recent comments.
Envista Is A Margin Improvement Story (Rating Upgrade)
Positive
Zacks Investment Research
1 month ago
Reasons to Retain Envista Stock in Your Portfolio for Now
NVST's strong focus on international market expansion appears promising. Yet, a leveraged balance sheet is worrisome.
Reasons to Retain Envista Stock in Your Portfolio for Now
Charts implemented using Lightweight Charts™